Interferon-gamma inhibits arterial stenosis after injury.
- 1 September 1991
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 84 (3), 1266-1272
- https://doi.org/10.1161/01.cir.84.3.1266
Abstract
BACKGROUNDArterial injury initiates a proliferative response among the smooth muscle cells of the artery. This leads to the formation of a thickened intima that may reduce the diameter of the arterial lumen. Such intimal lesions often develop after vascular surgery and angioplastic procedures. Previous cell culture studies have shown that the lymphokine, interferon-gamma (gIFN), inhibits smooth muscle cell proliferation.METHODS AND RESULTSWe therefore tested whether administration of exogenous gIFN could inhibit the development of intimal lesions. Rat carotid arteries were denuded with a balloon catheter, resulting in the formation of a standardized intimal lesion. The animals were then treated with recombinant rat gIFN at 200,000 units (approximately 400,000 units or 100 micrograms/kg body wt) administered parenterally once daily for 7 days. Autoradiographic analysis of 3H-thymidine incorporation revealed that gIFN reduced the early smooth muscle replication by approximately 75%. gIFN treatment for 1 wee...Keywords
This publication has 35 references indexed in Scilit:
- Cyclosporine A Inhibits Induction of DNA Synthesis by PDGF and Other Peptide Mitogens in Cultured Rat Aortic Smooth Muscle Cells and Dermal FibroblastsGrowth Factors, 1991
- Suppression of aortic atherosclerosis in cholesterol-fed rabbits by purified rabbit interferon.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AAScience, 1989
- Re-Stenosis after Successful Coronary AngioplastyNew England Journal of Medicine, 1988
- Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human AtheromaNew England Journal of Medicine, 1988
- Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.Journal of Clinical Investigation, 1988
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis.Journal of Clinical Investigation, 1985
- Suppression of experimental atherosclerosis in rabbits by interferon-inducing agentsJournal of the American College of Cardiology, 1984
- Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytesCell, 1977